Issue 5/2009
Content (8 Articles)
Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?
Gianna Fabbri, Aldo Pietro Maggioni
Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Carolyn F. Deacon, Jens J. Holst
Investigation of a multimarker approach to the initial assessment of patients with acute chest pain
C. J. McCann, B. M. Glover, I. B. A. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young, J. A. Adgey
Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE
Pierre Fontaine, Henri Gin, Michel Pinget, Charles Thivolet, Hélène Hanaire, Jean-Jacques Robert, Michel Marre, Srishyla Venkatanarasimhachar
Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis
Jane Castelli-Haley, MerriKay A. Oleen-Burkey, Maureen J. Lage, Kenneth P. Johnson
Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial
N. Bresolin, C. Zucca, A. Pecori